105 related articles for article (PubMed ID: 14673720)
1. Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients.
Abu Farsakh N
J Gastroenterol; 2003; 38(11):1042-8. PubMed ID: 14673720
[TBL] [Abstract][Full Text] [Related]
2. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
3. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
Howden CW; Henning JM; Huang B; Lukasik N; Freston JW
Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
[TBL] [Abstract][Full Text] [Related]
4. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
Richter JE; Kahrilas PJ; Sontag SJ; Kovacs TO; Huang B; Pencyla JL
Am J Gastroenterol; 2001 Nov; 96(11):3089-98. PubMed ID: 11721754
[TBL] [Abstract][Full Text] [Related]
5. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
[TBL] [Abstract][Full Text] [Related]
6. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
[TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.
Bigard MA; Genestin E
Aliment Pharmacol Ther; 2005 Oct; 22(7):635-43. PubMed ID: 16181303
[TBL] [Abstract][Full Text] [Related]
8. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
9. The effect of over-the-counter ranitidine 75 mg on night-time heartburn in patients with erosive oesophagitis on daily proton pump inhibitor maintenance therapy.
Vakil N; Guda N; Partington S
Aliment Pharmacol Ther; 2006 Mar; 23(5):649-53. PubMed ID: 16480404
[TBL] [Abstract][Full Text] [Related]
10. What do heartburn sufferers expect from proton pump inhibitors when prescribed for the first time?
Kamolz T; Pointner R
Minerva Gastroenterol Dietol; 2004 Jun; 50(2):143-7. PubMed ID: 15722984
[TBL] [Abstract][Full Text] [Related]
11. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
13. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
Cooper BT; Chapman W; Neumann CS; Gearty JC
Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174
[TBL] [Abstract][Full Text] [Related]
14. Heartburn severity does not predict disease severity in patients with erosive esophagitis.
Fennerty MB; Johnson DA
MedGenMed; 2006 Apr; 8(2):6. PubMed ID: 16926745
[TBL] [Abstract][Full Text] [Related]
15. Lansoprazole overutilization: methods for step-down therapy.
Pohland CJ; Scavnicky SA; Lasky SS; Good CB
Am J Manag Care; 2003 May; 9(5):353-8. PubMed ID: 12744297
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.
Fass R; Inadomi J; Han C; Mody R; O'Neil J; Perez MC
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):247-53. PubMed ID: 22155561
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related]
19. What is the best pharmacologic approach to managing moderate to severe heartburn?
Melton ST; Cimmino A
J Fam Pract; 2001 Oct; 50(10):839. PubMed ID: 11674880
[No Abstract] [Full Text] [Related]
20. Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials.
Wiklund I; Carlsson R; Carlsson J; Glise H
Scand J Gastroenterol; 2006 Mar; 41(3):288-93. PubMed ID: 16497615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]